Instituto Universitario de Investigación en Neuroquímica
Centre/Institut
Universidad Rey Juan Carlos
Madrid, EspañaPublications en collaboration avec des chercheurs de Universidad Rey Juan Carlos (17)
2024
-
Editorial: Current trends on emotional processing: contributions of acquired brain injury, neurodegenerative diseases, and ageing
Frontiers in Psychology
-
N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia
Translational Psychiatry, Vol. 14, Núm. 1
2023
-
Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study
The Journal of clinical psychiatry, Vol. 84, Núm. 2
-
Neuroimaging Revealed Long-Lasting Glucose Metabolism Changes to Morphine Withdrawal in Rats Pretreated with the Cannabinoid Agonist CP-55,940 during Periadolescence
European Neuropsychopharmacology, Vol. 69, pp. 60-76
2022
-
The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia
Frontiers in Pharmacology, Vol. 13
-
The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis
Journal of Psychiatric Research, Vol. 155, pp. 171-179
2021
-
A Characterization of the Effects of Minocycline Treatment during Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders
International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 734-748
-
Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease
European Journal of Pharmacology, Vol. 895
2017
-
Synthesis of a novel CB2 cannabinoid-porphyrin conjugate based on an antitumor chromenopyrazoledione
Journal of Porphyrins and Phthalocyanines, Vol. 21, Núm. 1, pp. 67-76
2014
-
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 73, pp. 56-72
-
Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results
Drug Design, Development and Therapy, Vol. 8, pp. 263-277
-
Subcellular distribution and early signalling events of P2X7 receptors from mouse cerebellar granule neurons
European Journal of Pharmacology, Vol. 744, pp. 190-202
2013
-
Description of a bivalent cannabinoid ligand with hypophagic properties
Archiv der Pharmazie, Vol. 346, Núm. 3, pp. 171-179
2012
-
Chromenopyrazoles: Non-psychoactive and Selective CB 1 Cannabinoid Agonists with Peripheral Antinociceptive Properties
ChemMedChem, Vol. 7, Núm. 3, pp. 452-463
-
Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation
Neurochemistry International, Vol. 61, Núm. 1, pp. 119-127
2011
-
Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: Role of CB2 receptors and iNOS/eNOS
Diabetes/Metabolism Research and Reviews, Vol. 27, Núm. 4, pp. 331-340
2003
-
New benzimidazole derivatives: Selective and orally active 5-HT3 receptor antagonists
European Journal of Pharmacology, Vol. 462, Núm. 1-3, pp. 99-107